Assessing data completeness in the international society for the study of pleura and peritoneum (ISSPP) PIPAC database: a multicenter evaluation from 2020-2024 [0.03%]
国际浆膜腔和腹膜研究学会（ISSPP）PIPAC数据库的数据完整性评估：2020年至2024年的多中心评价
Magnus Skov Jørgensen,Pernille Shjødt Hansen,Claus Wilki Fristrup et al.
Magnus Skov Jørgensen et al.
Objectives: In 2020, Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) reached stage 2b of the IDEAL framework and a prospective international PIPAC database was launched in June 2020 by the International Society f...
Adhesion obstacles effect on PIPAC patients with primary unresectable or recurrent platinum-resistant peritoneal metastasis from ovarian cancer [0.03%]
粘附障碍对卵巢癌原发不可切除或复发铂耐药性腹膜转移患者PIPAC的影响
Christos Iavazzo,Ioannis D Gkegkes
Christos Iavazzo
Comparison of clinical characteristics and outcomes between patients with complicated pleural infection caused by Streptococcus anginosus group and Klebsiella pneumoniae [0.03%]
由坏死性嗜血杆菌和肺炎克雷伯菌引起的继发性胸膜炎的临床特点及转归比较研究
Chang Ho Kim,Ji Eun Park,Sun Ha Choi et al.
Chang Ho Kim et al.
Objectives: Complicated pleural infections present significant challenges. Predominant causative microorganisms include the Streptococcus anginosus group (SAG) and Klebsiella pneumoniae (KP). However, limited data are ava...
The addition of collagenase to BromAc ® for the management of inoperable pseudomyxoma peritonei - in vitro results [0.03%]
BromAc®中添加胶原酶治疗不可手术的腹膜假黏液瘤的体外实验结果
Carissa Vici,Mathew Eapen,Pooja Narang et al.
Carissa Vici et al.
Objectives: Pseudomyxoma peritonei (PMP) is a rare peritoneal malignancy. BromAc ® is a novel therapeutic agent which has been developed to dissolve and facilitate the drainage of mucin as a palliative treatment for PMP;...
Advancements in nebulizers for pressurized intraperitoneal aerosol chemotherapy (PIPAC) [0.03%]
用于压腹给药化疗（PIPAC）的雾化器改进
Xiaosong Lin,Zifeng Yang,Yong Li
Xiaosong Lin
Introduction: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an innovative intraperitoneal drug delivery technique utilizing a nebulizer to aerosolize liquid chemotherapy agents under pressure, distributing t...
Co-occurrence of peritoneal mesothelioma and genitourinary cancers: a case series with comparative outcomes [0.03%]
腹膜间皮瘤与泌尿生殖系统肿瘤并发的病例系列研究及结局比较
Emma M Bradley,James L Rogers,Marissa C Kuo et al.
Emma M Bradley et al.
Objectives: Peritoneal mesothelioma (PM) shares features with genitourinary (GU) malignancies, including histologic appearance, embryologic origin and genetic predispositions. However, data on their co-occurrence are limi...
Real-world data on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed therapy in patients with peritoneal metastases; Third annual report from the ISSPP PIPAC database [0.03%]
腹膜转移患者使用压入式腹腔内化疗（PIPAC）治疗的真實世界數據；国际腹膜表面肿瘤协会( ISSPP )数据库第3年度报告
Magnus Skov Jørgensen,Pernille Schjødt Hansen,Claus W Fristrup et al.
Magnus Skov Jørgensen et al.
Objectives: In 2020, the International Society for the Study of the Pleura and Peritoneum (ISSPP) launched a database monitoring real-world data on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed therapy...
Treatment of peritoneal disease arising from mucinous vs. non-mucinous appendiceal neoplasms with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [0.03%]
腹膜炎性粘液性和非粘液性阑尾肿瘤的治疗：腹腔减瘤术和加热腹腔内化学疗法的作用
Rennie Xinrui Qin,Tilisi Puloka,Jia Hui Lim et al.
Rennie Xinrui Qin et al.
Objectives: Non-mucinous appendiceal neoplasms (NMAN) are rare. The role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating peritoneal dissemination from NMAN is poorly define...
Clinical utility of the peritoneal pathologic regression in gastric cancer patients associated to peritoneal metastasis. a study protocol [0.03%]
胃癌患者腹膜转移相关的腹膜病理退化的临床效用研究方案
Silvia Guerrero-Macías,María Eugenia Manrique-Acevedo,Carlos E Bonilla et al.
Silvia Guerrero-Macías et al.
Objectives: Peritoneal regression grade score (PRGS) has emerged a scoring system designed to measure the extent of residual disease following systemic or intraperitoneal therapies in patients with carcinomatosis. Higher ...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers [0.03%]
儿童和年轻人细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)的经验总结——两个治疗量大中心的报告
Maximilian Eckert,Michael Gerken,Jens M Werner et al.
Maximilian Eckert et al.
Objectives: peritoneal surface malignancy in children is rare with a dismal prognosis. This bicentric study evaluated CRS with HIPEC in patients aged 2-25 years. ...